| Market Cap | 622M 536M 503M 459M 865M 59.49B 868M 5.97B 2.33B 30.03B 2.34B 2.29B 99.58B | P/E 2027 * |
-9.1x | P/E 2028 * | -21.3x |
|---|---|---|---|---|---|
| Enterprise Value | 596M 513M 481M 439M 828M 56.93B 830M 5.71B 2.23B 28.74B 2.24B 2.19B 95.29B | EV / Sales 2027 * |
0.53x | EV / Sales 2028 * | 0.5x |
| Free-Float |
98.49% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : Tilray, Inc.
| 1 day | -5.59% |
| Manager | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CEO | Chief Executive Officer | 67 | 2021-04-30 |
Carl Merton
DFI | Director of Finance/CFO | 57 | 2021-04-30 |
Roger Savell
ADM | Chief Administrative Officer | 64 | 2022-03-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CHM | Chairman | 67 | 2021-04-30 |
David Clanachan
BRD | Director/Board Member | 64 | 2021-04-29 |
John Herhalt
BRD | Director/Board Member | 69 | 2021-04-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.59% | -15.99% | - | - | 620M | ||
| -0.13% | -6.44% | +60.47% | +112.05% | 1,048B | ||
| +0.85% | -0.81% | +52.77% | +63.15% | 640B | ||
| -1.03% | -3.58% | +22.87% | +73.29% | 456B | ||
| -1.46% | -4.50% | +37.43% | +38.41% | 362B | ||
| -0.72% | -2.89% | +21.86% | +36.79% | 295B | ||
| -1.19% | -2.21% | +1.35% | +12.29% | 255B | ||
| -1.05% | -1.57% | +51.40% | +68.55% | 236B | ||
| +0.08% | -1.78% | -17.64% | -54.29% | 204B | ||
| -2.14% | -0.30% | +29.42% | +89.10% | 185B | ||
| Average | -1.25% | -2.07% | +28.88% | +48.82% | 409.07B | |
| Weighted average by Cap. | -0.49% | -3.02% | +38.56% | +65.41% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.12B 968M 907M 828M 1.56B 107B 1.56B 10.76B 4.2B 54.17B 4.22B 4.12B 180B | 1.18B 1.01B 951M 868M 1.63B 112B 1.64B 11.28B 4.4B 56.77B 4.42B 4.32B 188B |
| Net income | -61.49M -52.99M -49.68M -45.35M -85.43M -5.88B -85.7M -589M -230M -2.97B -231M -226M -9.84B | -26.86M -23.15M -21.7M -19.81M -37.32M -2.57B -37.44M -258M -100M -1.3B -101M -98.67M -4.3B |
| Net Debt | -26.8M -23.09M -21.65M -19.76M -37.23M -2.56B -37.35M -257M -100M -1.29B -101M -98.42M -4.29B | -39.31M -33.87M -31.76M -28.99M -54.61M -3.76B -54.78M -377M -147M -1.9B -148M -144M -6.29B |
Employees
3,595
Sector
Pharmaceuticals
















